Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 117.00
-0.50 (-0.43%)
At close: Jul 9, 2026
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 7.82 billion as of July 9, 2026. Its market cap has decreased by -17.02% in one year.
Market Cap
7.82B
Enterprise Value
5.51B
Revenue
3.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
117.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 7.82B, an increase of 204.70%. That is a compound annual growth rate of 21.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 7.82B | -61.51% |
| Dec 31, 2025 | 20.31B | 114.84% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ScinoPharm Taiwan | 16.45B |
| Synmosa Biopharma | 16.42B |
| YungShin Global Holding | 14.52B |
| Grape King Bio | 13.50B |
| Foresee Pharmaceuticals | 13.15B |
| Standard Chemical & Pharmaceutical | 11.37B |
| Formosa Laboratories | 6.63B |
| Orient Pharma | 6.07B |